120 related articles for article (PubMed ID: 33508024)
1. Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study.
PLOS ONE Staff
PLoS One; 2021; 16(1):e0246489. PubMed ID: 33508024
[TBL] [Abstract][Full Text] [Related]
2. Perceived acceptability of progesterone to prevent preterm births and low birth weight among HIV-infected and HIV-uninfected Zambian pregnant women.
Wong JMH; Kanga N; Dogra N; Ngoma MS; Serghides L; Silverman M
Int J Womens Health; 2017; 9():827-833. PubMed ID: 29180906
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
Price JT; Vwalika B; Freeman BL; Cole SR; Mulenga HB; Winston J; Mbewe FM; Chomba E; Mofenson LM; Rouse DJ; Goldenberg RL; Stringer JSA
BMC Pregnancy Childbirth; 2019 Feb; 19(1):81. PubMed ID: 30813934
[TBL] [Abstract][Full Text] [Related]
4. Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study.
Price JT; Phiri WM; Freeman BL; Vwalika B; Winston J; Mabula-Bwalya CM; Mulenga HB; Stringer JSA
PLoS One; 2020; 15(1):e0224874. PubMed ID: 31995557
[TBL] [Abstract][Full Text] [Related]
5. Intimate Partner Violence Against HIV-Positive Women is Associated with Sub-Optimal Infant Feeding Practices in Lusaka, Zambia.
Hampanda K
Matern Child Health J; 2016 Dec; 20(12):2599-2606. PubMed ID: 27449651
[TBL] [Abstract][Full Text] [Related]
6. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human immunodeficiency virus in families in Lusaka, Zambia.
Hira SK; Nkowane BM; Kamanga J; Wadhawan D; Kavindele D; Macuacua R; Mpoko G; Malek M; Cruess DF; Perine PL
J Acquir Immune Defic Syndr (1988); 1990; 3(1):83-6. PubMed ID: 2293646
[TBL] [Abstract][Full Text] [Related]
8. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
[TBL] [Abstract][Full Text] [Related]
9. Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study.
Conkling M; Shutes EL; Karita E; Chomba E; Tichacek A; Sinkala M; Vwalika B; Iwanowski M; Allen SA
J Int AIDS Soc; 2010 Mar; 13():10. PubMed ID: 20230628
[TBL] [Abstract][Full Text] [Related]
10. Correction: Project YES! Youth Engaging for Success: A randomized controlled trial assessing the impact of a clinic-based peer mentoring program on viral suppression, adherence and internalized stigma among HIV-positive youth (15-24 years) in Ndola, Zambia.
Denison JA; Burke VM; Miti S; Nonyane BAS; Frimpong C; Merrill KG; Abrams EA; Mwansa JK
PLoS One; 2020; 15(4):e0232488. PubMed ID: 32324830
[TBL] [Abstract][Full Text] [Related]
11. Highly diverse anaerobe-predominant vaginal microbiota among HIV-infected pregnant women in Zambia.
Price JT; Vwalika B; Hobbs M; Nelson JAE; Stringer EM; Zou F; Rittenhouse KJ; Azcarate-Peril A; Kasaro MP; Stringer JSA
PLoS One; 2019; 14(10):e0223128. PubMed ID: 31577818
[TBL] [Abstract][Full Text] [Related]
12. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
[TBL] [Abstract][Full Text] [Related]
13. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
Martinez de Tejada B; Othenin-Girard V; Irion O
Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
[TBL] [Abstract][Full Text] [Related]
15. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
[TBL] [Abstract][Full Text] [Related]
17. Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study.
Azargoon A; Ghorbani R; Aslebahar F
Int J Reprod Biomed; 2016 May; 14(5):309-16. PubMed ID: 27326415
[TBL] [Abstract][Full Text] [Related]
18. Treatment options and recommendations to reduce preterm births in women with short cervix.
Slager J; Lynne S
J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
[TBL] [Abstract][Full Text] [Related]
19. Correction: Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected.
Kohli A; Islam A; Moyes DL; Murciano C; Shen C; Challacombe SJ; Naglik JR
PLoS One; 2020; 15(2):e0229553. PubMed ID: 32074132
[TBL] [Abstract][Full Text] [Related]
20. The Zambian Preterm Birth Prevention Study (ZAPPS): Cohort characteristics at enrollment.
Castillo MC; Fuseini NM; Rittenhouse K; Price JT; Freeman BL; Mwape H; Winston J; Sindano N; Baruch-Gravett C; Chi BH; Kasaro MP; Litch JA; Stringer JSA; Vwalika B
Gates Open Res; 2018; 2():25. PubMed ID: 30706053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
